Danaher DHR Property, plant, and equipment additions

Property, plant, and equipment additions at other companies

Thermo Fisher ScientificTMO

——

Diagnostics$195M—

Biotechnology$66M-17.5%

Life Sciences$57M—

Revenue$6.3B+5.5%

Gross profit$3.6B+2.5%

Operating income$1.1B+48.3%

Net income$870.0M+56.8%

EPS (diluted)$1.23+59.7%

Cash & equivalents$4.3B+47.0%

Total debt$27.9B+50.1%

Total equity$52.6B+0.5%

Total assets$92.4B+13.2%

Operating cash flow$1.5B+14.6%

CapEx$269.0M+8.5%

Free cash flow$1.3B+16.1%

Market cap$134.62B-7.4%

Enterprise value$158.13B-1.7%

P/E33.6×-9.0×

P/S5.4×-0.7×

Gross margin58.5%-1.1pp

Operating margin20.4%+2.0pp

Net margin15.9%+1.7pp

FCF margin21.8%+1.5pp

Return on equity7.6%+1.0pp

Debt / equity0.5×+0.2×

Current ratio1.7×0.0×